Factor VIII:C inhibitor associated with monoclonal-antibody purified FVIII concentrate
- 9 June 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 335 (8702), 1403
- https://doi.org/10.1016/0140-6736(90)91282-f
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Use of Recombinant Antihemophilic Factor in the Treatment of Two Patients with Classic HemophiliaNew England Journal of Medicine, 1989
- Induction of Immunotolerance in Hemophilia for High Titre Inhibitor Eradication: A Long-Term Follow-UpThrombosis and Haemostasis, 1989
- Anti‐idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitorsBritish Journal of Haematology, 1989
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitorsBlood, 1988
- Induction of immune tolerance to factor VIII in hemophiliacs with inhibitorsJAMA, 1988
- Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentratesAmerican Journal of Hematology, 1987